Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010–2019
Science Advances · 2024
DOI: 10.1126/sciadv.adg9674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Lawrence M Berger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sandra Rosenbaum School of Social Work and Institute for Research on Poverty, University of Wisconsin-Madison, Madison, WI 53706, USA. Hauptthemen laut MEDLINE: Medicaid, Prenatal Exposure Delayed Effects, Analgesics, Opioid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Prenatal opioid exposure is an established public health problem, in particular among Medicaid-covered births. Yet, existing prevalence rates are plausibly underestimated. We leverage extensive linked longitudinal administrative data for all Medicaid-covered live births in Wisconsin from 2010 to 2019 to estimate a range of prevalence rates using an innovative strategy that jointly accounts for both likelihood of exposure and potential risk to prenatal development. We find that 20.8% of infants may have been prenatally exposed to opioids, with 1.7% diagnosed with neonatal abstinence syndrome and an additional 1.2% having a high combined likelihood of exposure and potential risk to prenatal development, 2.6% a moderate combined likelihood and risk, and 15.3% a low or uncertain combined likelihood and risk. We assess improvements in prevalence estimates based on our nuanced classification relative to those of prior studies. Our strategy could be broadly used to quantify the scope of the opioid crisis for pregnant populations, target interventions, and promote child health and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sandra Rosenbaum School of Social Work and Institute for Research on Poverty, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Robert M. LaFollette of Public Affairs and Institute for Research on Poverty, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Department of Biobehavioral Health and Social Science Research Institute, Pennsylvania State University, University Park, PA 16802, USA.
- Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
ORCID-Profile: Lawrence M Berger, Christine Durrance, Deborah Ehrenthal, Hsiang-Hui Kuo, Jessica Pac
Förderung
- NICHD NIH HHS
Zitieren
APA
Berger, L. M., Durrance, C., Ehrenthal, D., Kim, H., Kuo, H. H., & Pac, J. (2024). Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010–2019. Science Advances. https://doi.org/10.1126/sciadv.adg9674
Vancouver
Berger LM, Durrance C, Ehrenthal D, Kim H, Kuo HH, Pac J. Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010–2019. Science Advances. 2024. doi:10.1126/sciadv.adg9674
BibTeX
@article{Berger2024,
author = {Berger, Lawrence M and Durrance, Christine and Ehrenthal, Deborah and Kim, HeeJin and Kuo, Hsiang-Hui and Pac, Jessica},
title = {Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010–2019},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adg9674}
}
EUVIMED